Center Of Target Therapy
Clinical trials sponsored by Center Of Target Therapy, explained in plain language.
-
New hope for hepatitis c: Two-Pill cure shows promise in early trial
⭐️ CURE ⭐️ OngoingThis study follows 30 adults with chronic hepatitis C (genotype 3) and mild liver damage who are taking ravidasvir plus sofosbuvir as part of their regular care. Researchers will check if the virus is gone from the blood 12 weeks after treatment ends (called SVR12), which indicat…
Sponsor: Center of target therapy • Aim: ⭐️ CURE ⭐️
Last updated May 26, 2026 11:26 UTC
-
Can a diabetes drug reverse fatty liver? new study aims to find out
Disease control OngoingThis study looks at how well the drug semaglutide works for people with metabolic fatty liver disease (MAFLD) and liver scarring. About 70 adults will take the drug for 3 years as part of their regular care. Researchers will check changes in liver fat, inflammation, and scarring …
Sponsor: Center of target therapy • Aim: Disease control
Last updated May 08, 2026 12:01 UTC